Clinical trial
Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)
NCT03947034 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)
- Lead sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2019
- Completion date
- April 4, 2023
- Enrollment
- 2,700 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adverse drug event, drug toxicity, hyperammonemia, metabolic disease